Volkan Sayin granted by the Swedish Cancer Society
Volkan Sayin has been awarded SEK 2.4 million from the Swedish Cancer Society. His project is about a platform for defining tumor-specific metabolic Achilles heels for individualized treatment of KRAS-driven non-small cell lung cancer.
Twenty-seven researchers at the University of Gothenburg have together received just over SEK 68 million for various research projects from the Swedish Cancer Society.
About Volkan Sayin Group
The Sayin lab is positioned in the intersection between lung cancer therapeutics, cancer metabolism and redox biology. We are building a precision medicine platform combining the latest technologies in lung cancer research and metabolomics to establish an extensive translational lung cancer group at Sahlgrenska Center for Cancer Research.